Male
Biotech executive with 20+ years of leadership in the life sciences industry. Currently, CEO of MediWound (Nasdaq: MDWD), advancing enzymatic therapeutics for wound and burn care. Proven track record in scaling innovation-driven companies through strategic partnerships, licensing deals, IPOs, and M&A. I’ve built and led high-performing teams across global markets, delivering patient-focused solutions with strong commercial potential.